No abstract available
MeSH terms
-
Administration, Intravenous
-
Child
-
Humans
-
Interleukin 1 Receptor Antagonist Protein* / adverse effects
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
-
Receptors, Antigen, T-Cell
-
Young Adult
Substances
-
Interleukin 1 Receptor Antagonist Protein
-
Receptors, Antigen, T-Cell
-
tisagenlecleucel